Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trialFei Ma, Binghe Xu, Wěi Li et al.|BMJ|2023Cited by 82
C1QL1 inhibits breast cancer through the HSP90α/VCP-ERS/UPR axisNingning Zhang, Xiaohua Zeng|Experimental & Molecular Medicine|2025Cited by 1